Alzheimer’s disease is an age-related brain disease often associated with profound cognitive decline. Recent research suggests that key aspects of the disease may be tightly intertwined with the body’s endocannabinoid system. In the near future, preventive measures for Alzheimer’s could foreseeably target parts of the endocannabinoid system and some treatments for Alzheimer’s could be cannabinoid-based.1
ALZHEIMER’S DISEASE
Description
![](https://freepngimg.com/download/social_media/63059-media-icons-telegram-twitter-blog-computer-social.png)
Stay updated, free articles. Join our Telegram channel
![](https://clinicalpub.com/wp-content/uploads/2023/09/256.png)
Full access? Get Clinical Tree
![](https://videdental.com/wp-content/uploads/2023/09/appstore.png)
![](https://videdental.com/wp-content/uploads/2023/09/google-play.png)